Gene therapy for fatal child brain disease may cause blood cancers
A gene therapy that halts a childhood-onset fatal brain disease has been associated with an increased risk of developing blood cancer...
Molly Godfrey is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. Molly currently works as a clinical scientist in genomics at the North West Genomics Laboratory Hub. She obtained her PhD in Cell and Molecular Biology at Cancer Research UK's London Research Institute (now subsumed into The Francis Crick Institute), where her work made use of budding yeast to further our understanding of the molecular mechanisms controlling cell replication. Previously, she studied Biological Sciences at the University of Warwick.
A gene therapy that halts a childhood-onset fatal brain disease has been associated with an increased risk of developing blood cancer...
Prostate cancer can be divided into two different genomic subtypes with implications for treatment strategies, new research has shown...
Adults with thalassemia, a severe genetic blood disorder, will be offered potentially curative stem cell transplants on the NHS for the first time...
The genome of chickens has been edited to make them partially resistant to infection with bird flu...
Transfer of mitochondrial DNA into the nuclear genome occurs in one in every 4000 births...
Repetitive sequences in noncoding DNA may lead to the generation of cancer-causing mutations...
An analysis of the whole genome sequences of around 12,000 patient tumours has revealed new mutational signatures in their DNA...
A group of genes known to regulate lifespan in model organisms such as fruit flies, has now been shown to impact longevity in humans...
The first 200,000 whole genomes to be sequenced as part of the UK Biobank project have been made widely available to researchers...
Identical twins carry a unique epigenetic signature on their DNA, providing potential clues as to how and why identical twinning occurs...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.